Baird's Investment Banking Group is pleased to announce the following transaction:

Date:
December 2021
Company:
Katena Products
Description:
Sale to Corza Medical
Sector(s):
Healthcare
Baird served as the exclusive financial advisor to Katena Products on this transaction

Katena Products (“Katena” or the “Company”), a portfolio company of Audax Private Equity ("Audax"), has successfully been acquired by Corza Medical (“Corza”), a GTCR portfolio company. Terms of the transaction were not disclosed.

Katena is a leading global provider of precision ophthalmic instruments and therapeutics to physician offices, hospitals, surgical centers, distributors, medical device OEMs and clinics. Founded in 1975 and headquartered in Parsippany, New Jersey, Katena’s product offering includes precision surgical instruments, single-use devices and specialty biologics that are sold into over 110 countries through a network of direct salespeople and distributors. Katena has more than 200 employees across Europe and North America and serves over 5,000 customers around the world.

Audax is a leading alternative investment manager with offices in Boston, New York, and San Francisco. Since its founding in 1999, the firm has raised over $30 billion in capital across its Private Equity and Private Debt businesses. Audax Private Equity has invested over $7 billion in more than 145 platforms and over 1,000 add-on companies, and is currently investing out of its $3.5 billion, sixth private equity fund. Through its disciplined Buy & Build approach, Audax Private Equity seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations and significantly increase equity value. With more than 300 employees, Audax is a leading capital partner for North American middle market companies.

Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 1,800 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill™ barbed sutures, Sharpoint™ Plus and Look™ surgical sutures, Sharpoint™ ophthalmic knives, and the TachoSil® fibrin sealant patch.

Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare, Technology, Media & Telecommunications, and Growth Business Services industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $20 billion in over 250 companies.

For additional information about this transaction, please contact:

Rob Andrews +1-312-609-5489
Luke Lapointe +1-312-609-4659
Les Cheek +1-617-426-5789
Andrew Nicholson +44-20-7667-8509